Tilray Inc Stock Today
| TLRY Stock | USD 1.69 0.01 0.59% |
Performance0 of 100
| Odds Of DistressOver 61
|
Tilray is trading at 1.69 as of the 5th of October 2024; that is 0.59 percent decrease since the beginning of the trading day. The stock's open price was 1.7. Tilray has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Tilray Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of August 2024 and ending today, the 5th of October 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of July 2018 | Category Healthcare | Classification Health Care |
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company has 875.44 M outstanding shares of which 98.17 M shares are at this time shorted by private and institutional investors with about 4.72 trading days to cover. More on Tilray Inc
Moving against Tilray Stock
Tilray Stock Highlights
| CEO President | Irwin Simon | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cannabis (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Health Care, Cannabis, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsTilray can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Tilray's financial leverage. It provides some insight into what part of Tilray's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tilray Inc (TLRY) is traded on NASDAQ Exchange in USA. It is located in 265 Talbot Street West, Leamington, ON, Canada, N8H 5L4 and employs 2,650 people. Tilray is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.48 B. Tilray Inc conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 875.44 M outstanding shares of which 98.17 M shares are at this time shorted by private and institutional investors with about 4.72 trading days to cover.
Tilray Inc currently holds about 490.64 M in cash with (30.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Check Tilray Probability Of Bankruptcy
Ownership AllocationTilray Inc shows a total of 875.44 Million outstanding shares. About 88.13 % of Tilray outstanding shares are held by general public with 0.69 (%) owned by insiders and only 11.18 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Tilray Ownership Details
Tilray Historical Income Statement
Tilray Stock Against Markets
Tilray Corporate Management
| Lloyd Brathwaite | Chief Officer | Profile | |
| Randy Daigneau | Senior Chain | Profile | |
| Mitchell Gendel | Global Secretary | Profile | |
| John Sadler | Vice Relations | Profile | |
| Nyree Pinto | Chief Officer | Profile |
Additional Tools for Tilray Stock Analysis
When running Tilray's price analysis, check to measure Tilray's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tilray is operating at the current time. Most of Tilray's value examination focuses on studying past and present price action to predict the probability of Tilray's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tilray's price. Additionally, you may evaluate how the addition of Tilray to your portfolios can decrease your overall portfolio volatility.